{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:17:31Z","timestamp":1778861851557,"version":"3.51.4"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02203-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:00:10Z","timestamp":1774854010000},"page":"2779-2797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting NF-\u03baB and JAK\/STAT pathways in rheumatoid arthritis: emerging nanocarrier-based drug delivery approaches"],"prefix":"10.1007","volume":"34","author":[{"given":"G.","family":"Surendra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Susithra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Jesudoss Prabhakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jasmine","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayakumar","family":"Subash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thukani Sathanantham","family":"Shanmugarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uppuluri Varuna","family":"Naga Venkata Arjun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konatham Teja Kumar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramana","family":"Hechhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"12","key":"2203_CR1","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/jbm.a.36765","volume":"107","author":"Q Ain","year":"2019","unstructured":"Ain Q, Zeeshan M, Khan S, Ali H (2019) Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis. J Biomedical Mater Res Part A 107(12):2595\u20132600","journal-title":"J Biomedical Mater Res Part A"},{"issue":"10","key":"2203_CR2","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","volume":"20","author":"L An","year":"2020","unstructured":"An L et al (2020) Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-\u03baB and Notch1 pathways. Nano Lett 20(10):7728\u20137736","journal-title":"Nano Lett"},{"key":"2203_CR3","doi-asserted-by":"publisher","first-page":"111880","DOI":"10.1016\/j.biopha.2021.111880","volume":"141","author":"C Anita","year":"2021","unstructured":"Anita C, Munira M, Mural Q, Shaily L (2021) Topical nanocarriers for management of Rheumatoid Arthritis: A review. Biomed Pharmacother 141:111880","journal-title":"Biomed Pharmacother"},{"issue":"42","key":"2203_CR4","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","volume":"42","author":"C Baldini","year":"2021","unstructured":"Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R (2021) The JAK\u2013STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J 42(42):4389\u20134400","journal-title":"Eur Heart J"},{"key":"2203_CR5","doi-asserted-by":"publisher","first-page":"153036","DOI":"10.1016\/j.phymed.2019.153036","volume":"63","author":"Y Bao","year":"2019","unstructured":"Bao Y et al (2019) Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK\/STAT and NF-\u03baB signaling pathways. Phytomedicine 63:153036","journal-title":"Phytomedicine"},{"issue":"4","key":"2203_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1476-5381.2009.00244.x","volume":"158","author":"A Bernardi","year":"2009","unstructured":"Bernardi A et al (2009) Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol 158(4):1104\u20131111","journal-title":"Br J Pharmacol"},{"issue":"6","key":"2203_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","volume":"74","author":"D Boyle","year":"2015","unstructured":"Boyle D et al (2015) The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis 74(6):1311\u20131316","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2203_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","volume":"59","author":"S de Brito Rocha","year":"2019","unstructured":"de Brito Rocha S, Baldo DC, Andrade LEC (2019) Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv Rheumatol 59(1):2","journal-title":"Adv Rheumatol"},{"issue":"4","key":"2203_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar2457","volume":"10","author":"KD Brown","year":"2008","unstructured":"Brown KD, Claudio E, Siebenlist U (2008) The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res therapy 10(4):212","journal-title":"Arthritis Res therapy"},{"issue":"12","key":"2203_CR10","doi-asserted-by":"publisher","first-page":"19665","DOI":"10.1021\/acsnano.2c06393","volume":"16","author":"MC Bruno","year":"2022","unstructured":"Bruno MC et al (2022) Injectable drug delivery systems for osteoarthritis and rheumatoid arthritis. ACS Nano 16(12):19665\u201319690","journal-title":"ACS Nano"},{"issue":"8","key":"2203_CR11","first-page":"5295","volume":"14","author":"B-C Chen","year":"2022","unstructured":"Chen B-C et al (2022) Network pharmacology-based approach uncovers the JAK\/STAT signaling mechanism underlying paederia scandens extract treatment of rheumatoid arthritis. Am J Translational Res 14(8):5295","journal-title":"Am J Translational Res"},{"issue":"1","key":"2203_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/nano8010042","volume":"8","author":"S-Y Chuang","year":"2018","unstructured":"Chuang S-Y, Lin C-H, Huang T-H, Fang J-Y (2018) Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials 8(1):42","journal-title":"Nanomaterials"},{"issue":"4","key":"2203_CR13","first-page":"3498","volume":"20","author":"DA Ciobanu","year":"2020","unstructured":"Ciobanu DA et al (2020) JAK\/STAT pathway in pathology of rheumatoid arthritis. Experimental therapeutic Med 20(4):3498\u20133503","journal-title":"Experimental therapeutic Med"},{"issue":"3","key":"2203_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/BOR.0b013e32834518a3","volume":"23","author":"FA Cooles","year":"2011","unstructured":"Cooles FA, Isaacs JD (2011) Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol 23(3):233\u2013240","journal-title":"Curr Opin Rheumatol"},{"key":"2203_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejps.2015.07.012","volume":"78","author":"K Coradini","year":"2015","unstructured":"Coradini K et al (2015) A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies. Eur J Pharm Sci 78:163\u2013170","journal-title":"Eur J Pharm Sci"},{"key":"2203_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-051X.2010.01669.x","volume":"38","author":"S Culshaw","year":"2011","unstructured":"Culshaw S, McInnes IB, Liew FY (2011) What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? J Clin Periodontol 38:106\u2013113","journal-title":"J Clin Periodontol"},{"key":"2203_CR17","doi-asserted-by":"publisher","first-page":"113560","DOI":"10.1016\/j.intimp.2024.113560","volume":"143","author":"C Deng","year":"2024","unstructured":"Deng C et al (2024) Sappanone A attenuates rheumatoid arthritis via inhibiting PI3K\/AKT\/NF-\u03baB and JAK2\/STAT3 signaling pathways in vivo and in vitro. Int Immunopharmacol 143:113560","journal-title":"Int Immunopharmacol"},{"key":"2203_CR18","doi-asserted-by":"publisher","first-page":"118786","DOI":"10.1016\/j.jep.2024.118786","volume":"337","author":"Y Deng","year":"2025","unstructured":"Deng Y et al (2025) Xuetongsu ameliorates synovial inflammatory hyperplasia in rheumatoid arthritis by inhibiting JAK2\/STAT3 and NF-\u03baB signaling pathways. J Ethnopharmacol 337:118786","journal-title":"J Ethnopharmacol"},{"key":"2203_CR19","doi-asserted-by":"crossref","unstructured":"Derksen V, Huizinga T, Van Der Woude D (2017) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Seminars in immunopathology, vol 39. Springer, pp 437\u2013446. 4","DOI":"10.1007\/s00281-017-0627-z"},{"key":"2203_CR20","doi-asserted-by":"publisher","first-page":"110238","DOI":"10.1016\/j.clim.2024.110238","volume":"264","author":"B Dreo","year":"2024","unstructured":"Dreo B et al (2024) JAK\/STAT signaling in rheumatoid arthritis leukocytes is uncoupled from serum cytokines in a subset of patients. Clin Immunol 264:110238","journal-title":"Clin Immunol"},{"issue":"1","key":"2203_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12951-018-0382-x","volume":"16","author":"W Duan","year":"2018","unstructured":"Duan W, Li H (2018) Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis. J Nanobiotechnol 16(1):58","journal-title":"J Nanobiotechnol"},{"key":"2203_CR22","doi-asserted-by":"publisher","first-page":"173238","DOI":"10.1016\/j.ejphar.2020.173238","volume":"882","author":"T Emori","year":"2020","unstructured":"Emori T et al (2020) Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: effect of the novel JAK inhibitor peficitinib. Eur J Pharmacol 882:173238","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2203_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-065X.2008.00626.x","volume":"223","author":"M Feldmann","year":"2008","unstructured":"Feldmann M, Maini SRN (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223(1):7\u201319","journal-title":"Immunol Rev"},{"issue":"10","key":"2203_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/1061186X.2018.1433680","volume":"26","author":"X Feng","year":"2018","unstructured":"Feng X, Chen Y (2018) Drug delivery targets and systems for targeted treatment of rheumatoid arthritis. J Drug Target 26(10):845\u2013857","journal-title":"J Drug Target"},{"issue":"2","key":"2203_CR25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1166\/jnn.2016.11673","volume":"16","author":"RB Friedrich","year":"2016","unstructured":"Friedrich RB, Coradini K, Fonseca FN, Guterres SS, Beck RC, Pohlmann AR (2016) Lipid-core nanocapsules improved antiedematogenic activity of tacrolimus in adjuvant-induced arthritis model. J Nanosci Nanotechnol 16(2):1265\u20131274","journal-title":"J Nanosci Nanotechnol"},{"issue":"9","key":"2203_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","volume":"53","author":"DE Furst","year":"2014","unstructured":"Furst DE, Emery P (2014) Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology 53(9):1560\u20131569","journal-title":"Rheumatology"},{"key":"2203_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.12.061","volume":"499","author":"NK Garg","year":"2016","unstructured":"Garg NK et al (2016) Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-\u03baB and FOXO1. Int J Pharm 499:1\u20132","journal-title":"Int J Pharm"},{"issue":"11","key":"2203_CR28","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1021\/acs.molpharmaceut.3c00581","volume":"20","author":"U Garg","year":"2023","unstructured":"Garg U, Jain N, Kaul S, Nagaich U (2023) Role of albumin as a targeted drug carrier in the management of rheumatoid arthritis: a comprehensive review. Mol Pharm 20(11):5345\u20135358","journal-title":"Mol Pharm"},{"issue":"7","key":"2203_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/1389557523666230913105803","volume":"24","author":"A Garhwal","year":"2024","unstructured":"Garhwal A, Kendya P, Soni S, Kori S, Soni V, Kashaw SK (2024) Drug delivery system approaches for rheumatoid arthritis treatment: a review. Mini Rev Med Chem 24(7):704\u2013720","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"2203_CR30","doi-asserted-by":"publisher","first-page":"167780","DOI":"10.1016\/j.bbadis.2025.167780","volume":"1871","author":"M Ghouri","year":"2025","unstructured":"Ghouri M et al (2025) Modified expression of JAK-STAT pathway genes in an in vivo rheumatoid arthritis model: a preclinical study to explore genetic insights, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1871(5):167780","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"4","key":"2203_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4155\/tde-2020-0029","volume":"11","author":"S Gorantla","year":"2020","unstructured":"Gorantla S, Singhvi G, Rapalli VK, Waghule T, Dubey SK, Saha RN (2020) Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status. Therapeutic delivery 11(4):269\u2013284","journal-title":"Therapeutic delivery"},{"key":"2203_CR32","doi-asserted-by":"publisher","first-page":"153801","DOI":"10.1016\/j.phymed.2021.153801","volume":"93","author":"X Guo","year":"2021","unstructured":"Guo X et al (2021) Anti-inflammatory and osteoprotective effects of Chikusetsusaponin \u2163a on rheumatoid arthritis via the JAK\/STAT signaling pathway. Phytomedicine 93:153801","journal-title":"Phytomedicine"},{"issue":"10","key":"2203_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr2.11093","volume":"1","author":"D Hammaker","year":"2019","unstructured":"Hammaker D et al (2019) Joint location\u2013specific JAK-STAT signaling in rheumatoid arthritis fibroblast\u2010like synoviocytes. ACR open Rheumatol 1(10):640\u2013648","journal-title":"ACR open Rheumatol"},{"issue":"11","key":"2203_CR34","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1002\/art.23986","volume":"58","author":"Y He","year":"2008","unstructured":"He Y et al (2008) Antiinflammatory effect of Rho kinase blockade via inhibition of NF-\u03baB activation in rheumatoid arthritis. Arthritis Rheumatism: Official J Am Coll Rheumatol 58(11):3366\u20133376","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"key":"2203_CR35","doi-asserted-by":"publisher","first-page":"4381212","DOI":"10.1155\/2020\/4381212","volume":"1","author":"L He","year":"2020","unstructured":"He L et al (2020) ErMiao San inhibits angiogenesis in rheumatoid arthritis by suppressing JAK\/STAT signaling pathways, Evidence-Based Complementary and Alternative Medicine, 1: 4381212, 2020","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"1","key":"2203_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13020-021-00510-6","volume":"16","author":"L He","year":"2021","unstructured":"He L et al (2021) Shikonin attenuates rheumatoid arthritis by targeting SOCS1\/JAK\/STAT signaling pathway of fibroblast like synoviocytes. Chin Med 16(1):96","journal-title":"Chin Med"},{"key":"2203_CR37","doi-asserted-by":"crossref","unstructured":"Helmy HS, El-Sahar AE, Sayed RH, Shamma RN, Salama AH, Elbaz EM (2017) Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis. Int J Nanomed, pp. 7015\u20137023","DOI":"10.2147\/IJN.S147738"},{"key":"2203_CR38","doi-asserted-by":"publisher","first-page":"109095","DOI":"10.1016\/j.intimp.2022.109095","volume":"111","author":"L Hu","year":"2022","unstructured":"Hu L, Liu R, Zhang L (2022) Advance in bone destruction participated by JAK\/STAT in rheumatoid arthritis and therapeutic effect of JAK\/STAT inhibitors. Int Immunopharmacol 111:109095","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2203_CR39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/rheumatology\/keu430","volume":"54","author":"P Isom\u00e4ki","year":"2015","unstructured":"Isom\u00e4ki P, Junttila I, Vidqvist K-L, Korpela M, Silvennoinen O (2015) The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels. Rheumatology 54(6):1103\u20131113","journal-title":"Rheumatology"},{"key":"2203_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejps.2016.05.014","volume":"91","author":"S Jafari","year":"2016","unstructured":"Jafari S, Maleki-Dizaji N, Barar J, Barzegar-Jalali M, Rameshrad M, Adibkia K (2016) Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations. Eur J Pharm Sci 91:225\u2013235","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2203_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/ard.2003.013276","volume":"63","author":"P Kasperkovitz","year":"2004","unstructured":"Kasperkovitz P et al (2004) Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 63(3):233\u2013239","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2203_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3831\/KPI.2019.22.029","volume":"22","author":"D Kesharwani","year":"2019","unstructured":"Kesharwani D, Paliwal R, Satapathy T, Paul SD (2019) Rheumatiod arthritis: an updated overview of latest therapy and drug delivery. J Pharmacopunct 22(4):210","journal-title":"J Pharmacopunct"},{"issue":"1","key":"2203_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/2772434418666230406083149","volume":"19","author":"S Khan","year":"2024","unstructured":"Khan S, Mohan K, Muzammil S, Alam MA, Khayyam KU (2024) Current prospects in rheumatoid arthritis: pathophysiology, genetics, and treatments. Recent Adv Anti-Infective Drug Discovery Former Recent Pat Anti-Infective Drug Discovery 19(1):36\u201355","journal-title":"Recent Adv Anti-Infective Drug Discovery Former Recent Pat Anti-Infective Drug Discovery"},{"issue":"1","key":"2203_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0126673878324613240805065651","volume":"19","author":"H Khan","year":"2025","unstructured":"Khan H, Yadav N, Sharma S, Rawat R (2025) Management of rheumatoid arthritis by development of nanocarriers and their significance over conventional dosage forms. Recent Adv Drug Delivery Formulation 19(1):2\u201315","journal-title":"Recent Adv Drug Delivery Formulation"},{"issue":"6","key":"2203_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ejlt.201400658","volume":"118","author":"N Kishore","year":"2016","unstructured":"Kishore N, Raja MD, Kumar CS, Dhanalekshmi U, Srinivasan R (2016) Lipid carriers for delivery of celecoxib: in vitro, in vivo assessment of nanomedicine in rheumatoid arthritis. Eur J Lipid Sci Technol 118(6):949\u2013958","journal-title":"Eur J Lipid Sci Technol"},{"key":"2203_CR46","doi-asserted-by":"publisher","first-page":"101946","DOI":"10.1016\/j.jddst.2020.101946","volume":"60","author":"SK Kottarath","year":"2020","unstructured":"Kottarath SK et al (2020) Folate receptor-\u03b2 targeted cholesterol-chitosan nanocarrier for treatment of rheumatoid arthritis: An animal study. J Drug Deliv Sci Technol 60:101946","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"2203_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/14728222.2017.1294160","volume":"21","author":"S Koushik","year":"2017","unstructured":"Koushik S et al (2017) PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis. Expert Opin Ther Targets 21(4):433\u2013447","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"2203_CR48","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s11095-016-2094-y","volume":"34","author":"V Kumar","year":"2017","unstructured":"Kumar V, Leekha A, Tyagi A, Kaul A, Mishra AK, Verma AK (2017) Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis. Pharm Res 34(3):654\u2013667","journal-title":"Pharm Res"},{"issue":"2","key":"2203_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/0115734137264937231214071646","volume":"21","author":"P Kumari","year":"2025","unstructured":"Kumari P, Jain SK, Saraf S, Tiwari A, Panda P, Verma A (2025) Emerging approaches for the treatment of rheumatoid arthritis: an outlook. Curr Nanosci 21(2):288\u2013308","journal-title":"Curr Nanosci"},{"issue":"1","key":"2203_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/nn301215q","volume":"7","author":"S-M Lee","year":"2013","unstructured":"Lee S-M et al (2013) Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. ACS Nano 7(1):50\u201357","journal-title":"ACS Nano"},{"key":"2203_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.actbio.2022.08.054","volume":"152","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1\u03b1\/NF-\u03baB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomater 152:406\u2013424","journal-title":"Acta Biomater"},{"key":"2203_CR52","doi-asserted-by":"publisher","first-page":"1113810","DOI":"10.3389\/fphar.2023.1113810","volume":"14","author":"J Li","year":"2023","unstructured":"Li J et al (2023) The mechanism of action of paeoniae radix rubra\u2013angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K\/AKT\/NF-\u03baB signaling pathway. Front Pharmacol 14:1113810","journal-title":"Front Pharmacol"},{"issue":"1","key":"2203_CR53","first-page":"23","volume":"2","author":"H Li","year":"2023","unstructured":"Li H et al (2023) Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment. Acta Materia Med 2(1):23\u201341","journal-title":"Acta Materia Med"},{"key":"2203_CR54","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.12659\/MSM.917396","volume":"25","author":"X Li","year":"2019","unstructured":"Li X, Qu J, Zhang T, He X, Jiang Y, Chen J (2019) Nuclear factor kappa B (NF-\u03baB) targeted self-assembled nanoparticles loaded with methotrexate for treatment of rheumatoid arthritis. Med Sci Monitor: Int Med J Experimental Clin Res 25:8204","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"12","key":"2203_CR55","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/1756-185X.13958","volume":"23","author":"J Li","year":"2020","unstructured":"Li J, Tang RS, Shi Z, Li JQ (2020) Nuclear factor-\u03baB in rheumatoid arthritis. Int J Rheum Dis 23(12):1627\u20131635","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"2203_CR56","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1007\/s12035-024-04634-2","volume":"62","author":"H Liao","year":"2025","unstructured":"Liao H, Zheng J, Lu J, Shen H-l (2025) NF-\u03baB signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential. Mol Neurobiol 62(6):6998\u20137021","journal-title":"Mol Neurobiol"},{"key":"2203_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molimm.2017.08.024","volume":"91","author":"Y-r Liu","year":"2017","unstructured":"Liu Y-r et al (2017) NLRC5 promotes cell proliferation via regulating the NF-\u03baB signaling pathway in Rheumatoid arthritis. Mol Immunol 91:24\u201334","journal-title":"Mol Immunol"},{"key":"2203_CR58","doi-asserted-by":"publisher","first-page":"122839","DOI":"10.1016\/j.biomaterials.2024.122839","volume":"314","author":"L Liu","year":"2025","unstructured":"Liu L et al (2025) Transformable peptide blocks NF-\u03baB\/I\u03baB\u03b1 pathway through targeted coating I\u03baB\u03b1 against rheumatoid arthritis. Biomaterials 314:122839","journal-title":"Biomaterials"},{"issue":"1","key":"2203_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-025-03481-3","volume":"27","author":"H Liu","year":"2025","unstructured":"Liu H et al (2025) Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK\/STAT signaling pathway. Arthritis Res Therapy 27(1):12","journal-title":"Arthritis Res Therapy"},{"issue":"3","key":"2203_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/ar3324","volume":"13","author":"G van Loo","year":"2011","unstructured":"van Loo G, Beyaert R (2011) Negative regulation of NF-\u03baB and its involvement in rheumatoid arthritis. Arthritis Res therapy 13(3):221","journal-title":"Arthritis Res therapy"},{"key":"2203_CR61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.actbio.2023.04.012","volume":"164","author":"Y Lu","year":"2023","unstructured":"Lu Y et al (2023) Glucocorticoid-loaded pH\/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-\u03baB signaling pathway. Acta Biomater 164:458\u2013473","journal-title":"Acta Biomater"},{"issue":"4","key":"2203_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/ar300","volume":"3","author":"SS Makarov","year":"2001","unstructured":"Makarov SS (2001) NF-\u03baB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res Therapy 3(4):200","journal-title":"Arthritis Res Therapy"},{"issue":"3","key":"2203_CR63","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/ijms18030484","volume":"18","author":"CJ Malemud","year":"2017","unstructured":"Malemud CJ (2017) Negative regulators of JAK\/STAT signaling in rheumatoid arthritis and osteoarthritis. Int J Mol Sci 18(3):484","journal-title":"Int J Mol Sci"},{"key":"2203_CR64","first-page":"5","volume":"10","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ (2018) The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Therapeutic Adv Musculoskelet disease 10:5\u20136","journal-title":"Therapeutic Adv Musculoskelet disease"},{"issue":"2","key":"2203_CR65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/14728222.12.2.171","volume":"12","author":"CJ Malemud","year":"2008","unstructured":"Malemud CJ, Miller AH (2008) Pro-inflammatory cytokine-induced SAPK\/MAPK and JAK\/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin Ther Targets 12(2):171\u2013183","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"2203_CR66","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/art.40569","volume":"70","author":"T McGarry","year":"2018","unstructured":"McGarry T et al (2018) JAK\/STAT blockade alters synovial bioenergetics, mitochondrial function, and proinflammatory mediators in rheumatoid arthritis. Arthritis Rheumatol 70(12):1959\u20131970","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2203_CR67","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/0115733971315944240712101011","volume":"21","author":"V Mittal","year":"2025","unstructured":"Mittal V, Sharma A, Sharma D (2025) Therapeutic potential of nanocarriers in the management of rheumatoid arthritis. Curr Rheumatol Reviews 21(3):252\u2013268","journal-title":"Curr Rheumatol Reviews"},{"issue":"1","key":"2203_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","volume":"48","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48(1):11\u201322","journal-title":"Rheumatology"},{"key":"2203_CR69","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.jddst.2021.102854","volume":"66","author":"A Munir","year":"2021","unstructured":"Munir A et al (2021) Synthesis of naringenin loaded lipid based nanocarriers and their in-vivo therapeutic potential in a rheumatoid arthritis model. J Drug Deliv Sci Technol 66:102854","journal-title":"J Drug Deliv Sci Technol"},{"issue":"17","key":"2203_CR70","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1039\/D2NA00229A","volume":"4","author":"S Nasra","year":"2022","unstructured":"Nasra S, Bhatia D, Kumar A (2022) Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment. Nanoscale Adv 4(17):3479\u20133494","journal-title":"Nanoscale Adv"},{"issue":"1","key":"2203_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","volume":"11","author":"L Nejatbakhsh Samimi","year":"2020","unstructured":"Nejatbakhsh Samimi L, Farhadi E, Tahmasebi MN, Jamshidi A, Sharafat A, Vaziri, Mahmoudi M (2020) NF-\u03baB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Autoimmun Highlights 11(1):11","journal-title":"Autoimmun Highlights"},{"issue":"6","key":"2203_CR72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cbin.10763","volume":"41","author":"Y Niu","year":"2017","unstructured":"Niu Y, Dong Q, Li R (2017) Matrine regulates Th1\/Th2 cytokine responses in rheumatoid arthritis by attenuating the NF-\u03baB signaling. Cell Biol Int 41(6):611\u2013621","journal-title":"Cell Biol Int"},{"issue":"1","key":"2203_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","volume":"17","author":"AR Noort","year":"2015","unstructured":"Noort AR, Tak PP, Tas SW (2015) Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Therapy 17(1):15","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"2203_CR74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/art.25063","volume":"62","author":"H Okamoto","year":"2010","unstructured":"Okamoto H, Yoshio T, Kaneko H, Yamanaka H (2010) Inhibition of NF-\u03baB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. Arthritis Rheumatism: Official J Am Coll Rheumatol 62(1):82\u201392","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"key":"2203_CR75","doi-asserted-by":"publisher","first-page":"738481","DOI":"10.3389\/fimmu.2021.738481","volume":"12","author":"M Palmroth","year":"2021","unstructured":"Palmroth M et al (2021) Tofacitinib suppresses several JAK-STAT pathways in rheumatoid arthritis in vivo and baseline signaling profile associates with treatment response. Front Immunol 12:738481","journal-title":"Front Immunol"},{"issue":"1","key":"2203_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/03639045.2016.1220563","volume":"43","author":"L-H Peng","year":"2017","unstructured":"Peng L-H, Wei W, Shan Y-H, Chong Y-S, Yu L, Gao J-Q (2017) Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo. Drug Dev Ind Pharm 43(1):55\u201366","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"2203_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1039\/D4NR03611E","volume":"17","author":"S Priya","year":"2025","unstructured":"Priya S, Jain KK, Daryani J, Desai VM, Kathuria H, Singhvi G (2025) Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward. Nanoscale 17(1):65\u201387","journal-title":"Nanoscale"},{"issue":"1","key":"2203_CR78","doi-asserted-by":"publisher","first-page":"e0244187","DOI":"10.1371\/journal.pone.0244187","volume":"16","author":"J Ptacek","year":"2021","unstructured":"Ptacek J et al (2021) Diminished cytokine-induced Jak\/STAT signaling is associated with rheumatoid arthritis and disease activity. PLoS ONE 16(1):e0244187","journal-title":"PLoS ONE"},{"key":"2203_CR79","doi-asserted-by":"publisher","first-page":"108644","DOI":"10.1016\/j.intimp.2022.108644","volume":"107","author":"W Qin","year":"2022","unstructured":"Qin W, Rong X, Yu C, Jia P, Yang J, Zhou G (2022) Knockout of SLAMF8 attenuates collagen-induced rheumatoid arthritis in mice through inhibiting TLR4\/NF-\u03baB signaling pathway. Int Immunopharmacol 107:108644","journal-title":"Int Immunopharmacol"},{"key":"2203_CR80","doi-asserted-by":"publisher","first-page":"102011","DOI":"10.1016\/j.jddst.2020.102011","volume":"61","author":"M Rabiei","year":"2021","unstructured":"Rabiei M, Kashanian S, Samavati SS, Derakhshankhah H, Jamasb S, McInnes SJ (2021) Nanotechnology application in drug delivery to osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OSP). J Drug Deliv Sci Technol 61:102011","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"2203_CR81","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3109\/21691401.2015.1036997","volume":"44","author":"R Raj","year":"2016","unstructured":"Raj R, Mongia P, Ram A, Jain N (2016) Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles. Artif Cells Nanomed Biotechnol 44(6):1434\u20131439","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2203_CR82","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.molimm.2021.03.024","volume":"134","author":"J Ren","year":"2021","unstructured":"Ren J et al (2021) Inhibition of regulator of G protein signaling 10, aggravates rheumatoid arthritis progression by promoting NF-\u03baB signaling pathway. Mol Immunol 134:236\u2013246","journal-title":"Mol Immunol"},{"issue":"9","key":"2203_CR83","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","volume":"14","author":"J Roman-Blas","year":"2006","unstructured":"Roman-Blas J, Jimenez S (2006) NF-\u03baB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil 14(9):839\u2013848","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR84","doi-asserted-by":"publisher","first-page":"1486476","DOI":"10.3389\/fimmu.2024.1486476","volume":"15","author":"D Seyedi","year":"2024","unstructured":"Seyedi D, Espandar N, Hojatizadeh M, Mohammadi Y, Sadri F, Rezaei Z (2024) Noncoding RNAs in rheumatoid arthritis: modulators of the NF-\u03baB signaling pathway and therapeutic implications. Front Immunol 15:1486476","journal-title":"Front Immunol"},{"key":"2203_CR85","doi-asserted-by":"publisher","first-page":"607585","DOI":"10.3389\/fmed.2021.607585","volume":"8","author":"W Shi","year":"2021","unstructured":"Shi W et al (2021) METTL3 promotes activation and inflammation of FLSs through the NF-\u03baB signaling pathway in rheumatoid arthritis. Front Med 8:607585","journal-title":"Front Med"},{"issue":"5","key":"2203_CR86","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/rheumatology\/kem298","volume":"47","author":"RE Simmonds","year":"2008","unstructured":"Simmonds RE, Foxwell BM (2008) Signalling, inflammation and arthritis: NF-\u03ba B and its relevance to arthritis and inflammation. Rheumatology 47(5):584\u2013590","journal-title":"Rheumatology"},{"key":"2203_CR87","doi-asserted-by":"crossref","unstructured":"Simon LS et al (2021) The Jak\/STAT pathway: A focus on pain in rheumatoid arthritis. Seminars in arthritis and rheumatism, vol 51. Elsevier, pp 278\u2013284. 1","DOI":"10.1016\/j.semarthrit.2020.10.008"},{"issue":"13","key":"2203_CR88","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2174\/1381612829666230406102935","volume":"29","author":"R Singh","year":"2023","unstructured":"Singh R, Jadhav K, Vaghasiya K, Ray E, Shukla R, Verma RK (2023) New generation smart drug delivery systems for rheumatoid arthritis. Curr Pharm Design 29(13):984\u20131001","journal-title":"Curr Pharm Design"},{"issue":"1","key":"2203_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13048\/jkm.14001","volume":"76","author":"YW Song","year":"2009","unstructured":"Song YW (2009) Updated pathophysiology of rheumatoid arthritis. Korean J Med 76(1):1\u20136","journal-title":"Korean J Med"},{"issue":"5","key":"2203_CR90","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1759720X10378372","volume":"2","author":"S Srirangan","year":"2010","unstructured":"Srirangan S, Choy EH (2010) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Therapeutic Adv Musculoskelet disease 2(5):247\u2013256","journal-title":"Therapeutic Adv Musculoskelet disease"},{"key":"2203_CR91","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.biopha.2018.07.027","volume":"106","author":"S Thakur","year":"2018","unstructured":"Thakur S, Riyaz B, Patil A, Kaur A, Kapoor B, Mishra V (2018) Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. Biomed Pharmacother 106:1011\u20131023","journal-title":"Biomed Pharmacother"},{"key":"2203_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lfs.2015.05.001","volume":"140","author":"\u00c9 Toussirot","year":"2015","unstructured":"Toussirot \u00c9, Michel F, Binda D, Dumoulin G (2015) The role of leptin in the pathophysiology of rheumatoid arthritis. Life Sci 140:29\u201336","journal-title":"Life Sci"},{"issue":"4","key":"2203_CR93","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/art.37834","volume":"65","author":"M Trenkmann","year":"2013","unstructured":"Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, Huber LC (2013) Tumor necrosis factor \u03b1\u2013induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF\u2010\u03baB signaling. Arthr Rhuem 65(4):916\u2013927","journal-title":"Arthr Rhuem"},{"key":"2203_CR94","doi-asserted-by":"crossref","unstructured":"Tyagi S, Pande MS, Islam M (2024) Recent insights and clinical status on novel mefenamic acid nanocarriers for the treatment of rheumatoid arthritis. Curr Nanomaterials","DOI":"10.2174\/0124054615305113240925101555"},{"issue":"1","key":"2203_CR95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12829","volume":"294","author":"M van Volkov","year":"2020","unstructured":"Volkov M, van Schie KA, van der Woude D, Autoantibodies, Cells B (2020) The ABC of rheumatoid arthritis pathophysiology. Immunol Rev 294(1):148\u2013163","journal-title":"Immunol Rev"},{"issue":"12","key":"2203_CR96","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/ard.2005.050385","volume":"65","author":"JG Walker","year":"2006","unstructured":"Walker JG et al (2006) Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment. Ann Rheum Dis 65(12):1558\u20131564","journal-title":"Ann Rheum Dis"},{"key":"2203_CR97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","volume":"122","author":"Q Wang","year":"2017","unstructured":"Wang Q et al (2017) Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials 122:10\u201322","journal-title":"Biomaterials"},{"issue":"2","key":"2203_CR98","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/jcb.26659","volume":"120","author":"Y Wang","year":"2019","unstructured":"Wang Y et al (2019) MiR-548a\u20103p regulates inflammatory response via TLR4\/NF\u2010\u03baB signaling pathway in rheumatoid arthritis. J Cell Biochem 120(2):1133\u20131140","journal-title":"J Cell Biochem"},{"key":"2203_CR99","doi-asserted-by":"publisher","first-page":"121874","DOI":"10.1016\/j.ijpharm.2022.121874","volume":"622","author":"X Wang","year":"2022","unstructured":"Wang X, Cao W, Sun C, Wang Y, Wang M, Wu J (2022) Development of pH-sensitive dextran-based methotrexate nanodrug for rheumatoid arthritis therapy through inhibition of JAK-STAT pathways. Int J Pharm 622:121874","journal-title":"Int J Pharm"},{"issue":"2","key":"2203_CR100","doi-asserted-by":"publisher","first-page":"152059","DOI":"10.1016\/j.imbio.2021.152059","volume":"226","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gao W (2021) Effects of TNF-\u03b1 on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-\u03baB signaling pathway. Immunobiology 226(2):152059","journal-title":"Immunobiology"},{"key":"2203_CR101","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2016.03.035","volume":"230","author":"Q Wang","year":"2016","unstructured":"Wang Q, Jiang J, Chen W, Jiang H, Zhang Z, Sun X (2016) Targeted delivery of low-dose dexamethasone using PCL\u2013PEG micelles for effective treatment of rheumatoid arthritis. J Controlled Release 230:64\u201372","journal-title":"J Controlled Release"},{"issue":"45","key":"2203_CR102","doi-asserted-by":"publisher","first-page":"23013","DOI":"10.1039\/D0NR05551D","volume":"12","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhan C, Zeng F, Wu S (2020) A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment via inhibiting JAK-STAT and JNK signalling pathways. Nanoscale 12(45):23013\u201323027","journal-title":"Nanoscale"},{"issue":"1","key":"2203_CR103","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13075-015-0824-x","volume":"17","author":"PR Wardwell","year":"2015","unstructured":"Wardwell PR, Forstner MB, Bader RA (2015) Investigation of the cytokine response to NF-\u03baB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models. Arthritis Res therapy 17(1):310","journal-title":"Arthritis Res therapy"},{"key":"2203_CR104","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejps.2013.09.013","volume":"51","author":"DR Wilson","year":"2014","unstructured":"Wilson DR, Zhang N, Silvers AL, Forstner MB, Bader RA (2014) Synthesis and evaluation of cyclosporine A-loaded polysialic acid\u2013polycaprolactone micelles for rheumatoid arthritis. Eur J Pharm Sci 51:146\u2013156","journal-title":"Eur J Pharm Sci"},{"issue":"23","key":"2203_CR105","doi-asserted-by":"publisher","first-page":"e10920","DOI":"10.1097\/MD.0000000000010920","volume":"97","author":"Z-B Xia","year":"2018","unstructured":"Xia Z-B et al (2018) Inhibition of NF-\u03baB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis. Medicine 97(23):e10920","journal-title":"Medicine"},{"key":"2203_CR106","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3389\/fimmu.2019.02218","volume":"10","author":"S Yan","year":"2019","unstructured":"Yan S et al (2019) Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4\/NF-\u03baB signaling pathway in rheumatoid arthritis. Front Immunol 10:2218","journal-title":"Front Immunol"},{"key":"2203_CR107","doi-asserted-by":"publisher","first-page":"155311","DOI":"10.1016\/j.phymed.2023.155311","volume":"124","author":"Y Yan","year":"2024","unstructured":"Yan Y et al (2024) Jolkinolide B ameliorates rheumatoid arthritis by regulating the JAK2\/STAT3 signaling pathway. Phytomedicine 124:155311","journal-title":"Phytomedicine"},{"issue":"9","key":"2203_CR108","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1002\/ptr.7853","volume":"37","author":"X Yang","year":"2023","unstructured":"Yang X et al (2023) Lonicerin alleviates the progression of experimental rheumatoid arthritis by downregulating M1 macrophages through the NF-\u03baB signaling pathway. Phytother Res 37(9):3939\u20133950","journal-title":"Phytother Res"},{"issue":"1","key":"2203_CR109","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12951-025-03576-8","volume":"23","author":"Y Yu","year":"2025","unstructured":"Yu Y et al (2025) Engineered Panax notoginseng polysaccharide micelles inhibit macrophage polarization and delay the progression of rheumatoid arthritis via JAK2-STAT3 signaling pathway. J Nanobiotechnol 23(1):509","journal-title":"J Nanobiotechnol"},{"key":"2203_CR110","doi-asserted-by":"publisher","first-page":"10953","DOI":"10.2147\/JIR.S530754","volume":"1","author":"Z Yu","year":"2025","unstructured":"Yu Z, Liu J, Chen L, Xie J (2025) Role of interleukin-6 in rheumatoid arthritis-associated interstitial lung disease: focus on the JAK\/STAT pathway and macrophage polarization. J Inflamm Res, 1: 10953\u201310967","journal-title":"J Inflamm Res"},{"issue":"24","key":"2203_CR111","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1039\/D4BM01058B","volume":"12","author":"MB Zewail","year":"2024","unstructured":"Zewail MB et al (2024) Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management. Biomaterials Sci 12(24):6163\u20136195","journal-title":"Biomaterials Sci"},{"issue":"7","key":"2203_CR112","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.xphs.2021.04.001","volume":"110","author":"M Zewail","year":"2021","unstructured":"Zewail M, Nafee N, Boraie N (2021) Intra-articular dual drug delivery for synergistic rheumatoid arthritis treatment. J Pharm Sci 110(7):2808\u20132822","journal-title":"J Pharm Sci"},{"issue":"1","key":"2203_CR113","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/10717544.2020.1818883","volume":"27","author":"F Zhang","year":"2020","unstructured":"Zhang F, Liu Z, He X, Li Z, Shi B, Cai F (2020) \u03b2-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund\u2019s adjuvant-induced arthritis in rats: involvement of NF-\u043aB and HO-1\/Nrf-2 pathway. Drug Delivery 27(1):1329\u20131341","journal-title":"Drug Delivery"},{"issue":"29","key":"2203_CR114","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1021\/acs.iecr.4c01304","volume":"63","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Zhang J (2024) Preparation of Tofacitinib-Loaded Poly (lactic-co-glycolic acid) Sustained Release Nanoparticles by High-Gravity Nanoprecipitation Technique and Its Performance in Rheumatoid Arthritis. Ind Eng Chem Res 63(29):12766\u201312777","journal-title":"Ind Eng Chem Res"},{"key":"2203_CR115","doi-asserted-by":"crossref","unstructured":"Zhao J et al (2017) Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomed, pp. 6735\u20136746","DOI":"10.2147\/IJN.S140992"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02203-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:02:50Z","timestamp":1778860970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02203-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02203-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}